Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation

Journal of Cell Biology

Volumn 179, Issue 2, 2007, Pages 305-319

  Deponti, Daniela ^a,b   François, Stéphanie ^c   Baesso, Silvia ^d   Sciorati, Clara ^d   Innocenzi, Anna ^d   Broccoli, Vania ^d   Muscatelli, Françoise ^e   Meneveri, Raffaella ^c   Clementi, Emilio ^b,f   Cossu, Giulio ^d,f   Brunelli, Silvia ^c,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e CNRS   (France)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MYOD PROTEIN; MYOGENIN; NECDIN; RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL FUSION; CELL SURVIVAL; CELLS, CULTURED; MICE; MICE, TRANSGENIC; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; MYOD PROTEIN; MYOGENIN; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REGENERATION; STEM CELLS; TRANS-ACTIVATION (GENETICS);

MUS; MUS MUSCULUS;

EID: 35549005030     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200701027     Document Type: Article

References (60)

1. Andrieu, D., H. Meziane, F. Marly, C. Angelats, P.A. Fernandez, and F. Muscatelli. 2006. Sensory defects in Necdin deficient mice result from a loss of sensory neurons correlated within an increase of developmental programmed cell death. BMC Dev. Biol. 6:56.
2. Ashe, P.C., and M.D. Berry. 2003. Apoptotic signaling cascades. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27:199-214.
3. Barker, P.A., and A. Salehi. 2002. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J. Neurosci. Res. 67:705-712.
4. Biressi, S., E. Tagliafico, G. Lamorte, S. Monteverde, E. Tenedini, E. Roncaglia, S. Ferrari, S. Ferrari, M.G. Cusella-De Angelis, S. Tajbakhsh, and G. Cossu. 2007. Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells. Dev. Biol. 304:633-651.
5. Bodega, B., M.F. Cardone, S. Muller, M. Neusser, F. Orzan, E. Rossi, E. Battaglioli, A. Marozzi, P. Riva, M. Rocchi, et al. 2007. Evolutionary genomic remodelling of the human 4q subtelomere (4q35.2). BMC Evol. Biol. 7:39.
6. Boeuf, S., M. Klingenspor, N.L. Van Hal, T. Schneider, J. Keijer, and S. Klaus. 2001. Differential gene expression in white and brown preadipocytes. Physiol. Genomics. 7:15-25.
7. Brunelli, S., E. Tagliafico, F.G. De Angelis, R. Tonlorenzi, S. Baesso, S. Ferrari, M. Niinobe, K. Yoshikawa, R.J. Schwartz, I. Bozzoni, and G. Cossu. 2004. Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ. Res. 94:1571-1578.
8. Buckingham, M., L. Bajard, P. Daubas, M. Esner, M. Lagha, F. Relaix, and D. Rocancourt. 2006. Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential. Anat. Embryol. (Berl.). 211:51-56.
9. Charge, S.B., and M.A. Rudnicki. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84:209-238.
10. Cooper, R.N., S. Tajbakhsh, V. Mouly, G. Cossu, M. Buckingham, and G.S. Butler-Browne. 1999. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J. Cell Sci. 112:2895-2901.
11. Cossu, G., and S. Biressi. 2005. Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin. Cell Dev. Biol. 16:623-631.
12. Cossu, G., B. Zani, M. Coletta, M. Bouche, M. Pacifici, and M. Molinaro. 1980. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells. Cell Differ. 9:357-368.
13. de la Serna, I.L., Y. Ohkawa, C.A. Berkes, D.A. Bergstrom, C.S. Dacwag, S.J. Tapscott, and A.N. Imbalzano. 2005. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol. Cell. Biol. 25:3997-4009.
14. Donehower, L., M. Harvey, B. Slagle, M. McArthur, C. Montgomery, J. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:215-221.
15. Edmondson, D.G., T.C. Cheng, P. Cserjesi, T. Chakraborty, and E.N. Olson. 1992. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell. Biol. 12:3665-3677.
16. Fielding, R.A., T.J. Manfredi, W. Ding, M.A. Fiatarone, W.J. Evans, and J.G. Cannon. 1993. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am. J. Physiol. 265:R166-R172.
17. Garry, D.J., A. Meeson, J. Elterman, Y. Zhao, P. Yang, R. Bassel-Duby, and R.S. Williams. 2000. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc. Natl. Acad. Sci. USA. 97:5416-5421.
18. Gerard, M., L. Hernandez, R. Wevrick, and C.L. Stewart. 1999. Disruption of the mouse necdin gene results in early post-natal lethality. Nat. Genet. 23:199-202.
19. Goldfine, A.B., S. Crunkhorn, M. Costello, H. Gami, E.J. Landaker, M. Niinobe, K. Yoshikawa, D. Lo, A. Warren, J. Jimenez-Chillaron, and M.E. Patti. 2006. Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue. Diabetes. 55:640-650.
20. Gordon, J.W. 1993. Production of transgenic mice. Methods Enzymol. 225:747-781.
21. Hampton, M.B., A.J. Kettle, and C.C. Winterbourn. 1998. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 92:3007-3017.
22. Iezzi, S., M. Di Padova, C. Serra, G. Caretti, C. Simone, E. Maklan, G. Minetti, P. Zhao, E.P. Hoffman, P.L. Puri, and V. Sartorelli. 2004. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev. Cell. 6:673-684.
23. Jiang, P., J. Song, G. Gu, E. Slonimsky, E. Li, and N. Rosenthal. 2002. Targeted deletion of the MLC1f/3f downstream enhancer results in precocious MLC expression and mesoderm ablation. Dev. Biol. 243:281-293.
24. Kobayashi, M., H. Taniura, and K. Yoshikawa. 2002. Ectopic expression of necdin induces differentiation of mouse neuroblastoma cells. J. Biol. Chem. 277:42128-42135.
25. Kuang, S., K. Kuroda, F. Le Grand, and M.A. Rudnicki. 2007. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell. 129:999-1010.
26. Kurita, M., T. Kuwajima, I. Nishimura, and K. Yoshikawa. 2006. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis. J. Neurosci. 26:12003-12013.
27. Kuwajima, T., H. Taniura, I. Nishimura, and K. Yoshikawa. 2004. Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J. Biol. Chem. 279:40484-40493.
28. Kuwajima, T., I. Nishimura, and K. Yoshikawa. 2006. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J. Neurosci. 26:5383-5392.
29. Kuwako, K., H. Taniura, and K. Yoshikawa. 2004. Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor. J. Biol. Chem. 279:1703-1712.
30. Kuwako, K., A. Hosokawa, I. Nishimura, T. Uetsuki, M. Yamada, S. Nada, M. Okada, and K. Yoshikawa. 2005. Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J. Neurosci. 25:7090-7099.
31. Lee, S.J., and A.C. McPherron. 2001. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA. 98:9306-9311.
32. Li, F.Q., A. Coonrod, and M. Horwitz. 2000. Selection of a dominant negative retinoblastoma protein (RB) inhibiting satellite myoblast differentiation implies an indirect interaction between MyoD and RB. Mol. Cell. Biol. 20:5129-5139.
33. Maruyama, K., M. Usami, T. Aizawa, and K. Yoshikawa. 1991. A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryonal carcinoma cells. Biochem. Biophys. Res. Commun. 178:291-296.
34. Matsumoto, K., H. Taniura, T. Uetsuki, and K. Yoshikawa. 2001. Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters. Gene. 272:173-179.
35. Musaro, A., and N. Rosenthal. 1999. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol. Cell. Biol. 19:3115-3124.
36. Muscatelli, F., D.N. Abrous, A. Massacrier, I. Boccaccio, M. Le Moal, P. Cau, and H. Cremer. 2000. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet. 9:3101-3110.
37. Niinobe, M., K. Koyama, and K. Yoshikawa. 2000. Cellular and subcellular localization of necdin in fetal and adult mouse brain. Dev. Neurosci. 22:310-319.
38. Pagliardini, S., J. Ren, R. Wevrick, and J.J. Greer. 2005. Developmental abnormalities of neuronal structure and function in prenatal mice lacking the prader-willi syndrome gene necdin. Am. J. Pathol. 167:175-191.
39. Perrotta, C., S. Falcone, A. Capobianco, A. Camporeale, C. Sciorati, C. De Palma, A. Pisconti, P. Rovere-Querini, M. Bellone, A.A. Manfredi, and E. Clementi. 2004. Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma. Cancer Res. 64:3767-3771.
40. Pisconti, A., S. Brunelli, M. Di Padova, C. De Palma, D. Deponti, S. Baesso, V. Sartorelli, G. Cossu, and E. Clementi. 2006. Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J. Cell Biol. 172:233-244.
41. Porrello, A., M. Cerone, S. Coen, A. Gurtner, G. Fontemaggi, L. Cimino, G. Piaggio, A. Sacchi, and S. Soddu. 2000. p53 regulates myogenesis by triggering the differentiation activity of pRb. J. Cell Biol. 151:1295-1304.
42. Rangwala, S.M., and M.A. Lazar. 2000. Transcriptional control of adipogenesis. Annu. Rev. Nutr. 20:535-559.
43. Relaix, F., D. Montarras, S. Zaffran, B. Gayraud-Morel, D. Rocancourt, S. Tajbakhsh, A. Mansouri, A. Cumano, and M. Buckingham. 2006. Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J. Cell Biol. 172:91-102.
44. Rosenblatt, J.D., A.I. Lunt, D.J. Parry, and T.A. Partridge. 1995. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell. Dev. Biol. Anim. 31:773-779.
45. Sabourin, L.A., A. Girgis-Gabardo, P. Seale, A. Asakura, and M.A. Rudnicki. 1999. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. 144:631-643.
46. Saelens, X., N. Festjens, L. Vande Walle, M. van Gurp, G. van Loo, and P. Vandenabeele. 2004. Toxic proteins released from mitochondria in cell death. Oncogene. 23:2861-2874.
47. Sciorati, C., P. Rovere, M. Ferrarini, S. Heltai, A.A. Manfredi, and E. Clementi. 1997. Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. J. Biol. Chem. 272:23211-23215.
48. Sciorati, C., B.G. Galvez, S. Brunelli, S. Ferrari, E. Tagliafico, G. Cossu, and E. Clementi. 2006. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J. Cell Sci. 119:5114-5123.
49. Tajbakhsh, S. 2005. Skeletal muscle stem and progenitor cells: reconciling genetics and lineage. Exp. Cell Res. 306:364-372.
50. Takazaki, R., I. Nishimura, and K. Yoshikawa. 2002. Necdin is required for terminal differentiation and survival of primary dorsal root ganglion neurons. Exp. Cell Res. 277:220-232.
51. Tamir, Y., and E. Bengal. 1998. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene. 17:347-356.
52. Taniura, H., N. Taniguchi, M. Hara, and K. Yoshikawa. 1998. Necdin, a post-mitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J. Biol. Chem. 273:720-728.
53. Taniura, H., K. Matsumoto, and K. Yoshikawa. 1999. Physical and functional interactions of neuronal growth suppressor necdin with p53. J. Biol. Chem. 274:16242-16248.
54. Tidball, J.G. 2005. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R345-R353.
55. Tseng, Y.H., A.J. Butte, E. Kokkotou, V.K. Yechoor, C.M. Taniguchi, K.M. Kriauciunas, A.M. Cypess, M. Niinobe, K. Yoshikawa, M.E. Patti, and C.R. Kahn. 2005. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 7:601-611.
56. Tutter, A.V., C.J. Fryer, and K.A. Jones. 2001. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev. 15:3342-3354.
57. Twiddy, D., D.G. Brown, C. Adrain, R. Jukes, S.J. Martin, G.M. Cohen, M. MacFarlane, and K. Cain. 2004. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J. Biol. Chem. 279:19665-19682.
58. Watrin, F., E. Le Meur, N. Roeckel, M.A. Ripoche, L. Dandolo, and F. Muscatelli. 2005. The Prader-Willi syndrome imprinting center is not involved in the spatio-temporal transcriptional regulation of the Necdin gene. BMC Genet. 6:1.
59. Yan, Z., S. Choi, X. Liu, M. Zhang, J.J. Schageman, S.Y. Lee, R. Hart, L. Lin, F.A. Thurmond, and R.S. Williams. 2003. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J. Biol. Chem. 278:8826-8836.
60. Zaccagnini, G., F. Martelli, P. Fasanaro, A. Magenta, C. Gaetano, A. Di Carlo, P. Biglioli, M. Giorgio, I. Martin-Padura, P.G. Pelicci, and M.C. Capogrossi. 2004. p66ShcA modulates tissue response to hindlimb ischemia. Circulation. 109:2917-2923.